AXGN Q2 2023 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$38M+10.7% YoY

Gross Profit

$30M77.7% margin

Operating Income

-$7M-18.1% margin

Net Income

-$7M-17.5% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

$292,000

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$192M

Total Liabilities

$94M

Stockholders' Equity

$97M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$34M	+10.7%
Gross Profit	$30M	$28M	+5.3%
Operating Income	-$7M	-$8M	+12.9%
Net Income	-$7M	-$8M	+14.0%